These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11390644)

  • 1. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
    Polonskaya Z; Benham CJ; Hearing J
    Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1995 Feb; 69(2):1280-3. PubMed ID: 7815506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1997 Mar; 71(3):1766-75. PubMed ID: 9032305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
    Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
    Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.
    Lindner SE; Sugden B
    Plasmid; 2007 Jul; 58(1):1-12. PubMed ID: 17350094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.
    Sugden B; Warren N
    J Virol; 1989 Jun; 63(6):2644-9. PubMed ID: 2542577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
    Koons MD; Van Scoy S; Hearing J
    J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Yates JL; Warren N; Sugden B
    Nature; 1985 Feb 28-Mar 6; 313(6005):812-5. PubMed ID: 2983224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins.
    Aiyar A; Sugden B
    J Biol Chem; 1998 Dec; 273(49):33073-81. PubMed ID: 9830062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
    Platt TH; Tcherepanova IY; Schildkraut CL
    J Virol; 1993 Mar; 67(3):1739-45. PubMed ID: 8382320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.
    Hodin TL; Najrana T; Yates JL
    J Virol; 2013 Dec; 87(23):13020-8. PubMed ID: 24067969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.